OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 128 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $13,000 | -81.9% | 23,883 | -42.9% | 0.00% | – |
| Q4 2015 | $72,000 | -62.1% | 41,831 | -53.6% | 0.00% | – |
| Q3 2015 | $190,000 | -37.1% | 90,244 | +47.7% | 0.00% | -100.0% |
| Q2 2015 | $302,000 | -36.3% | 61,085 | +0.8% | 0.00% | 0.0% |
| Q1 2015 | $474,000 | +28.8% | 60,589 | -0.1% | 0.00% | 0.0% |
| Q4 2014 | $368,000 | +35.8% | 60,647 | -4.5% | 0.00% | 0.0% |
| Q3 2014 | $271,000 | -34.4% | 63,521 | -5.0% | 0.00% | 0.0% |
| Q2 2014 | $413,000 | +3.2% | 66,856 | +8.7% | 0.00% | 0.0% |
| Q1 2014 | $400,000 | +61.3% | 61,509 | +39.7% | 0.00% | 0.0% |
| Q4 2013 | $248,000 | -9.8% | 44,032 | -1.9% | 0.00% | 0.0% |
| Q3 2013 | $275,000 | +13.2% | 44,871 | +8.0% | 0.00% | 0.0% |
| Q2 2013 | $243,000 | – | 41,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |